Baxter International Inc.

This committee assists with tax legislation and provides official revenue estimates. Its analysis and influence directly shape corporate tax structures and the overall tax burden, which is a major financial factor for Baxter.

This is a powerful committee controlling taxation, trade, and entitlement spending. Tax policy directly impacts Baxter's profitability, trade policy affects its global supply chain, and entitlement spending (e.g., Medicare/Medicaid reimbursement rates) significantly influences medical device sales and pricing.

This committee allocates discretionary federal spending. Its subcommittees determine specific funding for federal healthcare programs, scientific research (NIH), and VA/DoD healthcare, directly impacting potential government contracts and R&D opportunities for Baxter.

This committee directly regulates the FDA, which is crucial for medical device approvals and oversight. It also impacts labor laws affecting Baxter's workforce and influences healthcare policy and research funding (NIH).

This committee oversees intellectual property and antitrust laws. Patent protection is critical for medical device innovation, and antitrust oversight could impact Baxter's merger and acquisition activities, which are common in the industry.

This committee oversees the Department of Veterans Affairs. Funding decisions and policy for VA healthcare directly impact a significant potential customer base for Baxter's medical devices and supplies.